Nanoentek USA, Inc.

Nanoentek USA, Inc. — FDA 510(k) Submissions

Nanoentek USA, Inc. has submitted 5 FDA 510(k) premarket notifications since 2014, of which 5 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Radioimmunoassay, Thyroid-stimulating Hormone, Radioimmunoassay, Free Thyroxine, Radioimmunoassay, Testosterones And Dihydrotestosterone, Prostate-specific Antigen (psa) For Management Of Prostate Cancers, System, Test, Vitamin D . Use the specialty filter in the sidebar to narrow results.